Gujarat Inject Q1 net profit rises to ₹125.16 lakh

Gujarat Inject (Kerala) Ltd reported a net profit of ₹125.16 lakh for the first quarter ended June 30, 2026, a significant increase from ₹7.35 lakh in the same period last year. Revenue from operations surged to ₹1,245.45 lakh, driven by a substantial rise in sales compared to ₹242.12 lakh in Q1FY25. The company’s total income for the quarter stood at ₹1,245.45 lakh.

The Board of Directors approved the unaudited standalone financial results for the quarter at a meeting held on July 15, 2026. The results were reviewed by the Audit Committee and subsequently approved by the Board. M/s. S Mandawat & Co., Statutory Auditors of the Company, issued the Limited Review Report on the financial results.

Total expenses for Q1FY26 increased to ₹1,076.69 lakh from ₹232.30 lakh in the corresponding quarter of the previous year. This rise was primarily attributed to purchases of stock-in-trade, which amounted to ₹1,068.96 lakh, up from ₹225.86 lakh in Q1FY25. Employee benefit expenses and other expenses also saw an upward trend during the period.

The company’s profit before tax for the quarter stood at ₹168.76 lakh, compared to ₹9.82 lakh in Q1FY25. The tax expense for the period was ₹43.60 lakh. Earnings per share (EPS) for the quarter improved to ₹0.86 from ₹0.05 in the same period last year.

Financial Highlights for Q1FY26

Particulars	Q1FY26 (₹ in Lakh)	Q1FY25 (₹ in Lakh)
Revenue from Operations	1,245.45	242.12
Total Income	1,245.45	242.12
Total Expenses	1,076.69	232.30
Profit Before Tax	168.76	9.82
Net Profit	125.16	7.35
Basic EPS (₹)	0.86	0.05

The unaudited standalone financial results have been prepared in accordance with Indian Accounting Standards 34 "Interim Financial Reporting". The figures for the corresponding previous period have been restated or regrouped wherever necessary to ensure comparability. The company operates under a single reportable segment as per Ind AS 108.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
+1.86%	+3.24%	+17.09%	+243.36%	+490.52%	+5,608.33%

Gujarat Inject (Kerala) Ltd has appointed Mr. Murli Shivshankaran Nair as Managing Director effective July 6, 2026, for a term of three years. The appointment is subject to the approval of members in the ensuing general meeting. The Board of Directors approved the appointment during its meeting held on Monday, July 6, 2026.

Mr. Nair brings extensive experience to the role, particularly in the plastic industry. His profile indicates a deep understanding of manufacturing and administration, with a focus on customer and distributor requirements. The company stated that his proactive approach and competitive spirit are expected to contribute to business growth.

Key Managerial Personnel Authorization

Pursuant to Regulation 30(5) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company has authorized specific Key Managerial Personnel (KMP) to determine the materiality of events or information and make disclosures to stock exchanges.

Name & Designation	Address	Contact Details
Mr. Murli Shivshankaran Nair, Managing Director	A-416, Sun West Bank, Ashram Road P.O, Ahmedabad, City Ahmedabad, Gujarat, India, 380009	Email ID: gujaratinjectkeralaltd@gmail.com
Ms. Manmeetkaur Harshdeepsingh Bhatia, Company Secretary & Compliance Officer		Mo. No.: 816 003 8428

Regulatory Disclosures

The appointment was intimated to BSE Limited under Regulation 30 of the SEBI Listing Regulations. The company confirmed that Mr. Nair is not related to any of the existing directors and is not debarred from holding the office of director by any SEBI order or other authority. The Board meeting commenced at 03:45 P.M. and concluded at 04:15 P.M. on the same day.